We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScot.amer.inv. Regulatory News (SAIN)

Share Price Information for Scot.amer.inv. (SAIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 501.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.805%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 501.00
SAIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SAINTS Half-year results

1 Aug 2023 07:00

RNS Number : 7961H
Scottish American Investment Co PLC
01 August 2023
 

RNS Announcement

The Scottish American Investment Company P.L.C. (SAINTS)

 

Legal Entity Identifier: 549300NF03XVC5IFB447

Regulated Information Classification: Interim Financial Report.

 

The following is the unaudited Interim Financial Report for the six months to 30 June 2023 which was approved by the Board on 31 July 2023.

 

Results for the six months to 30 June 2023 and appointment of Deputy Manager

 

Results

¾ SAINTS' assets have delivered a strong positive return over the first six months of 2023, broadly keeping pace with equities. SAINTS' net asset value total return (borrowings at fair value) was 7.8% over the first six months of 2023, whilst global equities* returned 7.9% over the same period.

¾ Over the past five years the Company has outperformed both global equities and its sector, delivering a net asset value total return (borrowings at fair value) of 73.0% against the market's* total return of 56.7% and the sector's unweighted average net asset value total return of 50.0%.†

¾ The Company has declared a second interim dividend of 3.45p.

¾ SAINTS' revenues per share over the period were 7.64p compared to 7.78p for the equivalent period last year. The reduction in the Company's revenues is principally due to exchange rate movements and property sales, with the Company's equity holdings generally continuing to show dividend growth in local currency terms, helped by the Managers' emphasis on dependability.

¾ SAINTS' global equity portfolio outperformed global equities over the period despite the narrow leadership in equity markets.

¾ Despite a rising interest rate environment SAINTS' bond investments delivered a positive total return, as to a lesser extent did property. SAINTS' infrastructure equities fell back slightly.

¾ To satisfy market demand the Company issued £7.7m of shares over the period at a premium to Net Asset Value.

¾ The Board and the Managers are optimistic about SAINTS' long term prospects for growth.

 

* FTSE All-World Index (in sterling terms)

† Source: Morningstar/Baillie Gifford and relevant underlying service providers. See disclaimer at end of this announcement.

 

Appointment of Deputy Manager

¾ The Board is pleased to announce the appointment of Ross Mathison as Deputy Manager of SAINTS with immediate effect. Ross is an investment manager in Baillie Gifford's Global Income Growth team. This appointment reflects his close involvement in the management of SAINTS and Baillie Gifford's team based approach.

 

 

Pausing to look back: the long term case for dividend growth rather than yield

With SAINTS celebrating its 150th anniversary this year, we have been pausing to look back. Baillie Gifford was appointed investment manager by the Board in 2004. Financial markets were recovering from the dot com crash, the UK was still in the EU, and China was on its way to becoming a major driver of global growth after joining the World Trade Organisation in 2001.

As managers we inherited a portfolio which had focused on preserving yield, and which had become heavily skewed towards the UK: almost 70% of the equity portfolio was invested in London-listed stocks. We began a gradual process of moving the portfolio in a different direction. Focusing on growth rather than yield. And more expansive in terms of embracing investment opportunities globally.

At the time, SAINTS' competitors could essentially be regarded as the peer group of UK Equity Income funds. So, what happened next? The accompanying chart shows the income and capital growth delivered by SAINTS since 2004, compared with 26 such funds which are still going today. Of these 26, we were particularly interested in the 20 funds which, back in 2004, yielded more than 4%. These yield-focused funds had an average dividend yield of 4.7%, which was approximately a quarter higher than SAINTS' yield in 2004, which was 3.8%. 

The results can be seen in the chart. Despite its lower starting yield, SAINTS shareholders have received, over the period, more income than investments in the average high-yielding fund. Not by a wide margin, but a little bit more, despite starting at a significantly lower yield. The growth in dividends from SAINTS has surpassed the gap in starting yield, to the point that over the entire period, total income from SAINTS has been a little higher.

More strikingly, there is a stark difference in capital growth. SAINTS' shareholders have seen their capital grow by many multiples of the higher-yielding, UK-focused funds. An investment of £10,000 in 2004 delivered £24,000 of capital growth at SAINTS, compared with £5,300 for those yield-seeking funds.

Adding both income and capital growth, SAINTS' shareholders have seen their initial investment grow by 4.6x, whereas an investor in the average higher-yielding UK income fund would have seen their initial investment grow by 2.8x.

 

http://www.rns-pdf.londonstockexchange.com/rns/7961H_1-2023-7-31.pdf

 

 

We draw three conclusions from these numbers:

· A focus on dividend growth, rather than yield, does not mean shareholders receive less income than high-yielding strategies, over the long-term.

· These outcomes give credence to our belief that investing in companies that can compound their dividends relentlessly higher over long periods of time - the SAINTS approach - results in much higher capital growth. Relentless compounding of dividends requires relentless compounding of earnings. And relentless compounding of earnings drives share price appreciation, resulting in capital growth.

· It shows the benefits of investing globally. Of course, many UK-listed companies are global businesses, tapping into growth in other parts of the world. But the much wider universe of global opportunities provides much better odds of finding those relentless compounders of earnings and dividends.

 

Note that we have assumed, in our calculations, that investors were choosing to receive and consume their income, rather than reinvesting it into new shares of SAINTS (or their UK income fund). If we crunched these numbers again, but assumed reinvestment of dividends into new shares, we suspect the gap in outcomes would be even wider: given SAINTS' much stronger capital growth. We know that many SAINTS shareholders reinvest their dividends into new SAINTS shares.

 

Long-term compounders

Around 2013, Baillie Gifford expanded the team managing SAINTS. This gave us the resource to search the world for even more of the dividend compounders we seek. It also gave us an opportunity to stop and think about our investment approach. We decided to double-down. SAINTS leaned further into growth, and away from higher-yielding equities. 

Looking back on the companies that were owned within the portfolio in 2013 - many of which are still held today - we can see several examples of the growth stocks that have underpinned SAINTS' income and capital growth. The table below shows the ten best-performing holdings that we have held continuously for the past decade. (There have been other strong performers purchased since 2013, but here we are focussing on decade-long performance):

 

Company

cumulative

Total return GBP

cagr

Sales

cagr

EPS

cagr

PE

cagr

Share price

pa to cagr

Div addition

cagr

Total return local

cagr

Total return GBP

Apple

1820%

10%

14%

12%

28%

2%

32%

34%

Microsoft

1312%

10%

13%

11%

25%

1%

28%

30%

TSMC

715%

16%

20%

(1%)

18%

1%

28%

30%

Analog Devices

545%

16%

20%

1%

18%

2%

18%

20%

Partners Group

466%

15%

14%

(1%)

13%

2%

16%

19%

Atlas Copco

403%

8%

9%

7%

16%

3%

21%

18%

McDonald's

373%

(2%)

7%

4%

12%

2%

15%

17%

Rio Tinto

281%

3%

6%

1%

7%

4%

14%

14%

Pepsi

260%

3%

5%

3%

8%

2%

12%

14%

UPS

234%

6%

11%

(3%)

8%

2%

11%

13%

 

Source: Bloomberg and Baillie Gifford. Period 30 June 2013 to 30 June 2023

 

 

Some of the returns here are extraordinary. Investments such as Apple, Microsoft, TSMC, Analog Devices, Partners Group and Atlas Copco have all delivered share price appreciation better than 15% per annum, in local currency terms. After we add dividends into the equation, total returns have been even higher: 20 or 30% per annum in some cases. That means $1,000 invested ten years ago is worth about $11,800 today, in the example of Microsoft.

The foundation-stone beneath the total returns of these companies has been their strong revenue and earnings growth. By focusing on companies that we have judged likely to compound their earnings relentlessly higher at attractive rates - some 20% per annum in the case of TSMC and Analog Devices for example - we have found that share price appreciation has broadly followed. Sometimes this capital growth has been turbo-charged by expansion in the PE multiple, for example in the case of Apple. But the more important thing has been not to over-pay, risking PE compression that offsets the earnings growth. This way, the earnings growth has been more likely to translate into share price and capital growth.

Looking back today, in 2023, we believe more strongly than ever in our approach: focusing on growing companies that pay resilient dividends which should compound relentlessly away alongside their profit growth, all in the pursuit of strong income and capital growth for SAINTS shareholders. By looking globally for these companies, rather than narrowing our horizons to the particular island on which we happen to be based, we dramatically raise our odds of finding the next Atlas Copcos and Apples of the world. Over the long-term, we believe the laws of compounding make this approach highly likely to deliver better results than a value-oriented, yield-based approach to investing. 

 

 

Interim Management Report

 

Market commentary

Markets went down, up and occasionally sideways in the first half of 2023. It might be tempting to dismiss this as the usual gyrations of share prices and sentiment. But there are longer-term forces at play in recent market movements, which are worth commenting on here to help SAINTS shareholders understand what is happening.

The world economy is currently in a period of transition. The 2010s were an environment of low inflation and low interest rates. During the recent past we have seen inflation spike to levels not seen for many years, and central banks including the Bank of England attempt to wrestle inflation under control by continuously raising short-term borrowing rates. This has had, and will continue to have, knock-on effects in the broader economy. At times the market has plunged into despondency about the potential for recession, whilst at other times it has been euphoric about the prospect of inflation peaking and interest rates stabilising.

But what does it all mean for SAINTS' investments? Our belief is that the companies in the equity portfolio are much better-placed to continue growing their earnings and dividends than the average company in the stock market, despite the challenges that come with higher inflation and higher interest rates. For one thing, SAINTS' holdings have notably low levels of debt. This means that while other companies may struggle mightily in the next few years as they roll over their debt at significantly higher interest rates, this is unlikely to be much of a drag on profit growth for the companies in SAINTS' portfolio. Indeed some of SAINTS' holdings, such as Netease and Cognex, have net cash balance sheets and will see their earnings rise as they earn higher rates of interest.

We can also observe that SAINTS' holdings earn unusually high returns on equity, compared with the average company. This is essentially a reflection of the strong value they offer to their customers, which in turn helps them to pass on cost inflation where appropriate. We have seen this play out in some of their financial results since the start of the year. For example Coca-Cola recently reported revenue growth of 11% year over year.

These are some of the factors that give us confidence that, in this brave new world of higher interest rates, the impact on growth across SAINTS' equity portfolio will, hopefully, be relatively muted. Of course if economies fall into recession, growth may slow a little. But even then we might be hopeful that nominal growth in their dividends would continue. The typical SAINTS holding pays out perhaps half of its earnings as dividends. This means that even if these earnings fall, there is a large cushion that allows SAINTS' companies to look through the cycle and increase their dividends. We saw this during the past six months at TSMC, which despite forecasting a decline in sales of 10% this year due to the semiconductor cycle, said it foresees strong growth in its business in the medium-term and announced an increase in its dividend of 9%.

 

Performance

 

Over the first half of 2023, the equity portfolio delivered positive returns of approximately 8%, broadly in line with global equity markets. Interestingly, three of the top five contributors to performance were industrial companies: Watsco (the US distributor of air conditioning equipment), Fastenal (the US distributor of industrial parts) and French-listed Schneider Electric (automation and power management equipment).

"Interestingly" because, as mentioned above, investors have been worrying about the impact of rapidly rising interest rates on the economy and the risks of recession. But the results published by these companies have been far more resilient than the market anticipated.

Apart from these industrial names, Novo Nordisk was another strong contributor to performance over the past 6 months, on the back of excellent operational performance. Sales for Q1 2023, announced in May, were 25% higher than the previous year as its appetite suppressants continue to see rapidly rising demand from patients who are battling obesity.

Two Chinese holdings were the main drag on performance: furniture manufacturer Man Wah and sportswear company Anta Sports. Both published muted results in the period, affected by a disappointing rebound in the Chinese economy so far this year following the end of the strict lockdown policy last December. Our view is that in both cases their long-term growth prospects have not been markedly impacted, simply delayed, and their balance sheets and cash-flows remain very healthy.

Beyond the equity portfolio, we saw solid performance from SAINTS' investments in property, infrastructure equities, and bonds. These are funded out of SAINTS' prudent borrowings with an average cost of 3%.

Perhaps most notable was the property portfolio, managed by OLIM, which delivered a positive contribution to performance over the period as rental income more than offset a decline in capital values. The latest valuation, conducted externally by Savills, resulted in a handful of the properties being modestly marked down due to rising interest rates and falling market values for commercial property across the UK. But if we look at the 12 properties which were owned by SAINTS at the start of the year, and compare their values with the latest market valuation at 30 June 2023, we see that in aggregate their total value fell by only 2.4%, from £66.75m to £65.15m. This is a notable performance in a very difficult market for commercial property. If we add the two new properties purchased during the past six months (a hotel in Ringwood and an Aldi supermarket in Gosport) the total property portfolio has grown from £66.75m to £79.55m. Their rental income comfortably beats the cost of SAINTS' modest borrowings.

 

Investments and divestments

 

Two new equity holdings were added to the portfolio in the first half of the year: Coloplast and Eurofins.

Coloplast is a Danish-listed leading manufacturer of ostomy, incontinence, urology and wound care products, with significant European and global market shares. Its product engineering strengths in adhesives technology, combined with a mindset of continuous innovation, have enabled the company to develop profitable niche positions in markets with good prospects of continued compounding in earnings and dividends.

French-listed Eurofins Scientific is a laboratory business focused on a wide variety of testing related to food and the environment. Structural growth drivers of its business include expanding regulation and increased penetration of testing in developing countries. What makes us particularly enthusiastic about Eurofins is the distinctive vision of its founder, CEO and largest shareholder, Gilles Martin, who is resolutely focused on the long-term. Over the past three decades, the company has invested relentlessly in an industry-leading, internally developed technology platform and created a large global network of labs. We expect the combination of these two factors to provide solid foundations for growth and increasing returns on capital in the next decade and beyond.

So far this year, we have divested from four equity holdings: National Instruments, Silicon Motion, Linea Directa, and Cullen Frost.

National Instruments is an American manufacturer of hardware and software for lab researchers which has received a takeover bid at a price of $53 per share. We believe that the offer price is attractive and represents a healthy return on the fund's book cost, so we sold our position.

Silicon Motion, likewise, received a takeover offer. As we had received the final dividend and there was still uncertainty over the Chinese regulators' willingness to approve the deal, we decided to divest our position and put the capital to work in new ideas.

We invested in Linea Directa, a Spanish motor insurance company, only two years ago. However, the shares have proven to be highly illiquid, which meant we struggled to make this into the size of holding we envisaged. With no plan in sight to help improve liquidity, we decided to divest the holding.

Following a string of runs at US regional banks earlier this year, we decided that the risk facing Cullen Frost had turned unfavourably asymmetric, and we divested the holding to preserve capital.

 

ESG

 

We believe that investing sustainably is critical if we are to achieve our long-term objectives of delivering a dependable income and growing income and capital in real terms over the long term. In addition to the regular monitoring of our holdings and scoring potential new portfolio candidates using our Impact Ambition and Trust framework, our ESG analyst delved deep into two particular issues over the past few months: water management in Chile, and palm oil.

The water management report was to help us assess our investment in Albemarle, the world's largest lithium producer, and the potential risks to its growth prospects from water management around its operations in Chile. For a few weeks our analyst became a hydrogeologist, talking to academics, experts and NGOs to try and assess the impact of the company's practices in one of the world's most arid regions. His conclusion was that whilst lithium mining has some impact, the reduced water availability that has been observed in Chile in the past few years is more likely to be a function of the 13-year drought currently underway in the country, combined with much-larger water consumption by copper mining and agriculture. We will use this research to encourage Albemarle to expand their efforts to reduce water use and expand the monitoring of their impact on water in the area.

Palm oil, and the deforestation sometimes associated with its production, is another important issue with potential implications for our investments. Palm oil is in some ways a victim of its own success, with a broadening range of uses leading to global production rising fivefold over the past thirty years and making it the most used vegetable oil in the world. Advocates of palm oil point to the fact that it represents 36% of food oil globally but takes up less than 9% of land dedicated to that food oil production. Critics counter that not all land is created equal and palm oil production often replaces tropical forest with high carbon stock and richer biodiversity. Several of SAINTS' investments including Procter & Gamble, L'Oréal and PepsiCo are significant users of palm oil so we need to understand this particular issue.

Our research has highlighted a few important points. Much progress has been made in terms of sustainability certification and many companies are now dedicating resources to ensure their palm oil is grown sustainably. On the other hand, a large number of small independent suppliers, combined with a lot of intermediary processing steps, make traceability and transparency very challenging, and a key area for companies to address. This has helped us to have more informed discussions with our companies - indeed we raised it with Procter & Gamble while visiting them in Cincinnati last month - and this has helped us to establish a set of measures and policies we expect our holdings to adopt, if they have not already done so.

 

Outlook

 

After reflecting back on the occasion of SAINTS' 150th, we take several lessons forward. One is the rewards from focusing on long-term dividend growth rather than short-term dividend yield. Another is the expansion of opportunities afforded by a global portfolio. A third is the exceptional returns that outstanding companies can generate for SAINTS shareholders.

This year, as every year, the gyrations of markets and economies creates a great deal of uncertainty and speculation. But for the long-term investor in great companies, faced with opportunities such as Coloplast or Eurofins or indeed any of the investments within SAINTS' portfolio, we see the potential for many years of continued resilient income together with attractive growth in capital.

We are proud to be managers of SAINTS, and the trust put in us by the Board. We hope that in the decade ahead, as in the nearly two-decades past, we can continue to earn that trust by delivering attractive returns to SAINTS shareholders.

 

 

Baillie Gifford & Co

31 July 2023

 

See disclaimer at the end of this announcement.

Past performance is not a guide to future performance.

 

Responsibility Statement

We confirm that to the best of our knowledge:

a) the condensed set of Financial Statements has been prepared in accordance with FRS 104 'Interim Financial Reporting';

b) the Interim Management Report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.7R (indication of important events during the first six months, their impact on the Financial Statements and a description of principal risks and uncertainties for the remaining six months of the year); and

c) the Interim Financial Report includes a fair review of the information required by Disclosure Guidance and Transparency Rule 4.2.8R (disclosure of related party transactions and changes therein).

 

By order of the Board

Lord Macpherson of Earl's Court

Chairman

31 July 2023

Income Statement (unaudited)

 

 

For the six months ended

30 June 2023

For the six months ended

30 June 2022

For the year ended

31 December 2022 (audited)

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains on sales of investments - securities

17,939 

17,939 

1,586 

1,586 

12,200 

12,200 

Gains on sales of investments - property

-

607 

607 

2,042 

2,042 

Changes in fair value of investments - securities

 - 

 38,544 

 38,544 

(105,210)

(105,210)

 (92,291)

(92,291)

Changes in fair value of investments - property

 (2,167)

 (2,167)

1,543 

1,543 

(7,156)

(7,156)

Currency (losses)/gains

 (39)

 (39)

71 

71 

192 

192 

Income - dividends and interest

 14,493 

 14,493 

14,486 

14,486 

25,488 

25,488 

Income - rent and other

 2,348 

 2,348 

2,412 

2,412 

4,555 

4,555 

Management fees (note 3)

 (514)

 (1,542)

 (2,056)

(494)

(1,481)

(1,975)

(980)

(2,940)

(3,920)

Other administrative expenses

 (634)

 (634)

(574)

(574)

(1,257)

-

(1,257)

Net return before finance costs and taxation

 15,693 

 52,735 

 68,428 

15,830 

(102,884)

(87,054)

27,806 

(87,953)

(60,147)

Finance costs of borrowings

 (354)

 (1,061)

 (1,415)

(565)

(1,695)

(2,260)

(921)

(2,763)

(3,684)

Net return on ordinary activities before taxation

 15,339 

 51,674 

 67,013 

15,265 

(104,579)

(89,314)

26,885 

(90,716)

(63,831)

Tax on ordinary activities

 (1,811)

 506 

 (1,305)

(1,562)

429 

(1,133)

(2,540)

790 

(1,750)

Net return on ordinary activities after taxation

 13,528 

 52,180 

 65,708 

13,703 

(104,150)

(90,447)

24,345 

(89,926)

(65,581)

Net return per ordinary share (note 4)

7.64p

29.46p

37.10p

7.78p

(59.16p)

(51.38p)

13.82p

(51.04p)

(37.22p)

Note:

Dividends paid and payable per share

(note 5)

 

 

6.75p

 

 

 

 

6.65p

 

 

13.82p

 

The accompanying notes below are an integral part of the Financial Statements.

The total column of this statement is the profit and loss account of the Company. The supplementary revenue and capital columns are prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in the above statements derive from continuing operations.

A Statement of Comprehensive Income is not required as all gains and losses of the Company have been reflected in the above statement.

 

 Balance Sheet (unaudited)

 

 

 

At 30 June

2023

£'000

At 31 December

2022

(audited)

£'000

Non-current assets

Investments - securities

919,024

869,837

Investments - property

79,550

66,750

 998,574

936,587

Current assets

Debtors

3,886

3,213

Cash and deposits

2,682

4,184

6,568

7,397

Creditors

Amounts falling due within one year:

Other creditors and accruals

(2,654)

(2,596)

Net current assets

 3,914

4,801

Total assets less current liabilities

1,002,488

941,388

Creditors

Amounts falling due after more than one year:

Loan notes (note 7)

(94,721)

(94,714)

Net assets

907,767

846,674

Capital and reserves

Share capital

44,551

44,188

Share premium account

185,559

178,189

Capital redemption reserve

22,781

22,781

Capital reserve

635,994

583,814

Revenue reserve

18,882

17,702

Shareholders' funds

 907,767

846,674

Net asset value per ordinary share*

 509.4p

479.0p

Ordinary shares in issue (note 8)

178,205,943

176,750,943

 

* See Glossary of Terms and Alternative Performance Measures at the end of this announcement.

 

The accompanying notes below are an integral part of the Financial Statements.

 

 

 

 

Statement of Changes in Equity (unaudited)

For the six months ended 30 June 2023

 

Share capital

£'000

Share premium account

£'000

Capital redemption reserve

£'000

 

Capital reserve *

£'000

 

Revenue reserve

£'000

 

Shareholders'

funds

£'000

Shareholders' funds at 1 January 2023

44,188

178,189

22,781

583,814

17,702

846,674

Shares issued

363

7,370

-

-

-

7,733

Net return on ordinary activities after taxation

-

-

-

52,180

13,528

65,708

Dividends paid (note 5)

 -

-

-

-

(12,348)

(12,348)

Shareholders' funds at 30 June 2023

44,551

185,559

22,781

635,994

18,882

907,767

 

 

For the six months ended 30 June 2022

 

Share capital

£'000

Share premium account

£'000

Capital redemption reserve

£'000

 

Capital reserve *

£'000

 

Revenue reserve

£'000

 

Shareholders'

funds

£'000

Shareholders' funds at 1 January 2022

43,900

172,576

22,781

673,740

17,188

930,185

Shares issued

175

3,434

-

-

-

3,609

Net return on ordinary activities after taxation

-

-

-

(104,150)

13,703

(90,447)

Dividends paid (note 5)

-

-

-

-

(11,666)

(11,666)

Shareholders' funds at 30 June 2022

44,075

176,010

22,781

569,590

19,225

831,681

 

* The Capital Reserve balance at 30 June 2023 includes investment holding gains of £317,109,000 (30 June 2022 - gains of £276,512,000).

 

The accompanying notes below are an integral part of the Financial Statements.

Cash Flow Statement (unaudited)

 

 

 

Six months to

 30 June

2023

£'000

Six months to

 30 June

2022

£'000

Cash flows from operating activities

Net return on ordinary activities before taxation

 67,013

(89,314)

Net (gains)/losses on investments - securities

(56,483)

 103,624

Net losses/(gains) on investments - property

 2,167

(2,150)

Currency losses/(gains)

 39

(71)

Finance costs of borrowings

 1,415

 2,260

Overseas withholding tax

(1,291)

(1,140)

Changes in debtors

(687)

(130)

Changes in creditors

 73

 571

Other non-cash changes

 80

 120

Cash from operations

 12,326

 13,770

Interest paid

(1,422)

(3,368)

Net cash inflow from operating activities

 10,904

 10,402

Cash flows from investing activities

Acquisitions of investments - securities

(68,321)

(38,252)

Acquisitions of investments - property

(14,967)

(8,239)

Disposals of investments - securities

 75,535

 36,174

Disposals of investments - property

 -

 3,589

Net cash outflow from investing activities

(7,753)

(6,728)

Cash flows from financing activities

Equity dividends paid

(12,348)

(11,666)

Shares issued

 7,734

 3,609

Loan notes drawn down

-

 80,000

Debenture stock repaid

-

(80,000)

Costs of issuance of debt

-

(16)

Net cash outflow from financing activities

(4,614)

(8,073)

Decrease in cash and cash equivalents

(1,463)

(4,399)

Exchange movements

(39)

 71

Cash and cash equivalents at start of period*

 4,184

 11,263

Cash and cash equivalents at end of period*

 2,682

 6,935

 

* Cash and cash equivalents represent cash at bank and short term money market deposits repayable on demand.

 

The accompanying notes below are an integral part of the Financial Statements.

 

Performance Attribution for the Six Months to 30 June 2023 (unaudited)

 

 

 

Portfolio breakdown

Average allocation

SAINTS

%

Average allocation Benchmark †

%

 

 

 

Total return

SAINTS

%

Total return Benchmark †

%

Global Equities

 94.5

100.0

8.5

7.9

Infrastructure Equities

 2.8

(0.8)

Bonds

 4.5

4.5

Direct Property

 8.1

0.2

Deposits

0.7

-

Borrowings at book value

 (10.6)

1.5

Portfolio Total Return (borrowings at book value)

7.9

 

Other items*

(0.1)

Fund Total Return (borrowings at book value)

7.8

Adjustment for change in fair value of borrowings

-

Fund Total Return (borrowings at fair value)

7.8

The above returns are calculated on a total returns basis with net income reinvested.

Source: Baillie Gifford and relevant underlying index providers.

* Includes Baillie Gifford and OLIM management fees.

 See disclaimer at the end of this announcement.

Past performance is not a guide to future performance.

 

 

Twenty Largest Equity Holdings at 30 June 2023 (unaudited)

 

 

Name

 

Business

Value

£'000

% of total

assets *

Novo Nordisk

Pharmaceutical company

 36,801

3.7

Watsco

Distributes air conditioning, heating and refrigeration equipment

 34,254

3.4

Microsoft

Computer software

 34,063

3.4

Fastenal

Distribution and sales of industrial supplies

 29,800

3.0

Procter & Gamble

Household product manufacturer

 27,738

2.8

Taiwan Semiconductor Manufacturing

Semiconductor manufacturer

 26,589

2.7

Apple

Consumer technology

 25,509

2.5

Pepsico

Snack and beverage company

 25,383

2.5

United Parcel Service

Courier services

 24,616

2.5

Sonic Healthcare

Laboratory testing

 22,501

2.2

Analog Devices

Integrated circuits

 22,433

2.2

Roche

Pharmaceuticals and diagnostics

 21,973

2.2

Atlas Copco

Engineering

 21,836

2.2

Deutsche Boerse

Securities exchange owner/operator

 21,172

2.1

Schneider Electric

Electrical power products

 20,854

2.1

Coca Cola

Beverage company

 18,608

1.8

Experian

Credit scoring and marketing services

 18,294

1.8

Nestlé

Food producer

 17,802

1.8

Edenred

Voucher programme outsourcer

 17,665

1.8

Wolters Kluwer

Information services and solutions provider

 17,255

1.7

485,146

 48.4

* Before deduction of borrowings.

 

Notes to the Condensed Financial Statements (unaudited)

1 The condensed Financial Statements for the six months to 30 June 2023 comprise the statements set out above together with the related notes below. They have been prepared in accordance with FRS 104 'Interim Financial Reporting' and the AIC's Statement of Recommended Practice issued in November 2014 and updated in July 2022 with consequential amendments and have not been audited or reviewed by the Auditor pursuant to the Auditing Practices Board Guidance 'Review of Interim Financial Information'. The Financial Statements for the six months to 30 June 2023 have been prepared on the basis of the same accounting policies as set out in the Company's Annual Report and Financial Statements at 31 December 2022.

Going Concern

The Directors have considered the nature of the Company's principal risks and uncertainties, as set out on the inside front cover, together with its current position. The Board has, in particular, considered macroeconomic and geopolitical concerns, including the Russia-Ukraine conflict, increased inflation and interest rates but does not believe the Company's going concern status is affected. In addition, the Company's investment objective and policy, its assets and liabilities and projected income and expenditure, together with the Company's dividend policy, have been taken into consideration and it is the Directors' opinion that the Company has adequate resources to continue in operational existence for the foreseeable future. The Company's assets, the majority of which are investments in quoted securities which are readily realisable, exceed its liabilities significantly. All borrowings require the prior approval of the Board. Gearing levels and compliance with borrowing covenants are reviewed by the Board on a regular basis. The Company has no short term borrowings. The redemption dates for the Company's loan notes are June 2036, April 2045 and April 2049. Accordingly, the Directors consider it appropriate to adopt the going concern basis of accounting in preparing these Financial Statements and confirm that they are not aware of any material uncertainties which may affect the Company's ability to continue to do so over a period of at least twelve months from the date of approval of these Financial Statements.

2 The financial information contained within this Interim Financial Report does not constitute statutory accounts as defined in sections 434 to 436 of the Companies Act 2006. The financial information for the year ended 31 December 2022 has been extracted from the statutory accounts which have been filed with the Registrar of Companies. The Auditor's Report on those accounts was not qualified, and did not contain statements under sections 498(2) or (3) of the Companies Act 2006.

3 Baillie Gifford & Co Limited, a wholly owned subsidiary of Baillie Gifford & Co, has been appointed by the Company as its Alternative Investment Fund Manager (AIFM) and Company Secretary. The investment management function has been delegated to Baillie Gifford & Co. The management agreement can be terminated on six months' notice. The annual management fee, calculated quarterly, is 0.45% on the first £500m of total assets and 0.35% on the remaining total assets, where 'total assets' is defined as the total value of the assets held, excluding the value of the property portfolio, less all liabilities (other than any liability in the form of debt intended for investment purposes).

As AIFM, Baillie Gifford & Co Limited has delegated the management of the property portfolio to OLIM Property Limited. OLIM receives an annual fee from SAINTS of 0.5% of the value of the property portfolio, subject to a minimum quarterly fee of £6,250. The agreement can be terminated on three months' notice.

4 Net Return per Ordinary Share

 

 

Six months to 30 June 2023

£'000

Six months to 30 June 2022

£'000

Revenue return on ordinary activities after taxation

13,528

13,703

Capital return on ordinary activities after taxation

52,180

(104,150)

Total net return

65,708

(90,447)

Weighted average number of ordinary shares in issue

177,095,723

176,051,800

 

 

 

 

5 Dividends

 

 

Six months to 30 June 2023

£'000

Six months to 30 June 2022

£'000

Amounts recognised as distributions in the period:

 

 

Previous year's final of 3.67p (2022 - 3.375p), paid 13 April 2023

6,487

5,937

First interim of 3.30p (2022 - 3.25p), paid 22 June 2023

5,861

5,730

12,348

11,667

Amounts paid and payable in respect of the period:

 

 

First interim of 3.30p (2022 - 3.25p), paid 22 June 2023

5,861

5,730

Second interim of 3.45p (2022 - 3.40p)

6,148

5,994

12,009

11,724

The second interim dividend was declared after the period end date and therefore has not been included as a liability in the Balance Sheet.

It is payable on 20 September 2023 to shareholders on the register at the close of business on 11 August 2023. The ex-dividend date is 10 August 2023. The Company's Registrar offers a Dividend Reinvestment Plan and the final date for elections for this dividend is 30 August 2023.

6 Fair Value Hierarchy

The fair value hierarchy used to analyse the basis on which the fair values of financial instruments held at fair value through the profit or loss account are measured is described below. Fair value measurements are categorised on the basis of the lowest level input that is significant to the fair value measurement.

Level 1 - using unadjusted quoted prices for identical instruments in an active market;

Level 2 - using inputs, other than quoted prices included within Level 1, that are directly or indirectly observable (based on market data); and

Level 3 - using inputs that are unobservable (for which market data is unavailable).

An analysis of the Company's financial asset investments based on the fair value hierarchy described above is shown below.

 

 

As at 30 June 2023

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Securities

 

 

 

 

Listed equities

880,897

-

-

880,897

Bonds

-

38,127

-

38,127

Property

 

Freehold

-

-

79,550

79,550

Total financial asset investments

880,897

38,127

79,550

998,574

 

 

 

As at 31 December 2022

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Securities

 

 

 

 

Listed equities

826,397

-

-

826,397

Bonds

-

43,440

-

43,440

Property

 

 

 

 

Freehold

-

-

66,750

66,750

Total financial asset investments

826,397

43,440

66,750

936,587

 

There have been no transfers between levels of the fair value hierarchy during the period. The fair value of listed investments is bid value or, in the case of holdings on certain recognised overseas exchanges, last traded price. They are categorised as Level 1 if they are valued using unadjusted quoted prices for identical instruments in an active market and Level 2 if they do not meet all these criteria but are, nonetheless, valued using market data. The fair value of unlisted investments is determined using valuation techniques, determined by the Directors, based upon observable and/or non-observable data such as latest dealing prices, stockbroker valuations, net asset values and other information, as appropriate. The Company's holdings in unlisted investments are categorised as Level 3 as the valuation techniques applied include the use of non-observable data.

7 At 30 June 2023, the book value of the borrowings was £94,721,000 (31 December 2022 - £94,714,000) and the fair value was £62,760,000 (31 December 2022 - £65,549,000). The debt comprises long-term private placement loan notes: £15 million with a coupon of 2.23% issued during 2021 and £80 million with a coupon of 3.12% issued to refinance the 8% Debenture Stock which matured on 10 April 2022.

8 At 30 June 2023, the Company had the authority to buy back 26,494,966 ordinary shares and to issue 16,220,094 ordinary shares without application of pre-emption rights in accordance with the authorities granted at the AGM in April 2023. During the six months to 30 June 2023, 1,455,000 (31 December 2022 - 1,150,000) shares were issued at a premium to net asset value raising proceeds of £7,733,000 (31 December 2022 - £5,901,000). No shares were bought back (31 December 2022 - nil).

9 Related Party Transactions

There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or the performance of the Company during that period and there have been no changes in the related party transactions described in the last Annual Report and Financial Statements that could have had such an effect on the Company during that period.

10 The Interim Financial Report will be available on the SAINTS page of the Managers' website: saints-it.com‡ on or around 15 August 2023.

 

Principal Risks and Uncertainties

The principal risks facing the Company are financial risk, investment strategy risk, climate and governance risk, regulatory risk, custody and depositary risk, operational risk, discount risk, leverage risk, political risk, cyber security risk and emerging risks. An explanation of these risks and how they are managed is set out on pages 8 to 10 of the Company's Annual Report and Financial Statements for the year to 31 December 2022 which is available on the Company's website: saints-it.com.

The principal risks and uncertainties have not changed since the date of that report.

 

Glossary of Terms and Alternative Performance Measures (APM)

Total Assets

Total assets less current liabilities, before deduction of all borrowings.

Net Asset Value

Net Asset Value (NAV) is the value of total assets less liabilities (including borrowings). The NAV per share is calculated by dividing this amount by the number of ordinary shares in issue.

Net Asset Value (Borrowings at Book Value)

Borrowings are valued at adjusted net issue proceeds. Book value approximates amortised cost.

Net Asset Value (Borrowings at Fair Value) (APM)

Borrowings are valued at an estimate of their market worth.

 

 

30 June

2023

31 December

2022

Shareholders' funds (borrowings at book value)

£907,767,000 

£846,674,000 

Add: book value of borrowings

£94,721,000 

£94,714,000 

Less: fair value of borrowings

(£62,760,000)

(£65,549,000)

Shareholders' funds (borrowings at fair value)

£939,728,000 

£875,839,000 

Shares in issue

178,205,943 

 176,750,943 

Net Asset Value per ordinary share (borrowings at fair value)

527.3p

 495.5p

Discount/Premium (APM)

As stockmarkets and share prices vary, an investment trust's share price is rarely the same as its NAV. When the share price is lower than the NAV per share it is said to be trading at a discount. The size of the discount is calculated by subtracting the share price from the NAV per share and is usually expressed as a percentage of the NAV per share. If the share price is higher than the NAV per share, this situation is called a premium.

 

30 June

2023

NAV (book)

30 June

2023

NAV (fair)

31 December

2022

NAV (book)

31 December

2022

NAV (fair)

Closing NAV per share

509.4p

527.3p

479.0p

495.5p

Closing share price

522.0p

522.0p

508.0p

508.0p

Premium/(discount)

2.5%

(1.0%)

6.1%

2.5%

Total Return (APM)

The total return is the return to shareholders after reinvesting the net dividend on the date that the share price goes ex-dividend.

 

30 June

2023

NAV (book)

30 June

2023

NAV (fair)

30 June

2023

share price

31 December

2022

NAV (book)

31 December

2022

NAV (fair)

31 December

2022

share price

Opening NAV per share/share price

(a)

479.0p

495.5p

508.0p

529.7p

528.4p

541.0p

Closing NAV per share/share price

(b)

509.4p

527.3p

522.0p

479.0p

495.5p

508.0p

Dividend adjustment factor* 

(c)

1.013742

1.012896

1.013027

1.027330

1.026941

1.027687

Adjusted closing NAV per share/share price

(d = b x c)

516.4p

534.1p

528.8p

492.1p

508.8p

522.1p

Total return

(d ÷ a)-1

7.8%

7.8%

4.1%

(7.1%)

(3.7%)

(3.5%)

* The dividend adjustment factor is calculated on the assumption that the dividends paid out by the Company are reinvested into the shares of the Company at the cum income NAV/share price, as appropriate, at the ex-dividend date.

Ongoing Charges (APM)

The total expenses (excluding borrowing costs) incurred by the Company as a percentage of the average net asset value (with borrowings at fair value). The ongoing charges have been calculated on the basis prescribed by the Association of Investment Companies.

Performance Attribution (APM)

Analysis of how the Company achieved its performance relative to its benchmark.

Gearing (APM)

At its simplest, gearing is borrowing. Just like any other public company, an investment trust can borrow money to invest in additional investments for its portfolio. The effect of the borrowing on the shareholders' assets is called 'gearing'. If the Company's assets grow, the shareholders' assets grow proportionately more because the debt remains the same. But if the value of the Company's assets falls, the situation is reversed. Gearing can therefore enhance performance in rising markets but can adversely impact performance in falling markets.

Gearing represents borrowings at book less cash and cash equivalents expressed as a percentage of shareholders' funds.

Potential gearing is the Company's borrowings expressed as a percentage of shareholders' funds.

Equity gearing is the Company's borrowings adjusted for cash, bonds and property expressed as a percentage of shareholders' funds.

Leverage (APM)

For the purposes of the Alternative Investment Fund Managers (AIFM) Directive, leverage is any method which increases the Company's exposure, including the borrowing of cash and the use of derivatives. It is expressed as a ratio between the Company's exposure and its net asset value and can be calculated on a gross and a commitment method. Under the gross method, exposure represents the sum of the Company's positions after the deduction of sterling cash balances, without taking into account any hedging and netting arrangements. Under the commitment method, exposure is calculated without the deduction of sterling cash balances and after certain hedging and netting positions are offset against each other.

Active Share (APM)

Active share, a measure of how actively a portfolio is managed, is the percentage of the listed equity portfolio that differs from its comparative index. It is calculated by deducting from 100 the percentage of the portfolio that overlaps with the comparative index. An active share of 100 indicates no overlap with the index and an active share of zero indicates a portfolio that tracks the index.

 

‡ Neither the contents of the Managers' website nor the contents of any website accessible from hyperlinks on the Managers' website (or any other website) is incorporated into, or forms part of, this announcement.

None of the views expressed in this document should be construed as advice to buy or sell a particular investment.

 

SAINTS' objective is to deliver real dividend growth by increasing capital and growing income. Its policy is to invest mainly in equity markets, but other investments may be held from time to time including bonds, property and other asset classes.

 

Baillie Gifford & Co Limited, a wholly owned subsidiary of Baillie Gifford & Co, is appointed as investment managers and secretaries to SAINTS. Baillie Gifford & Co, the Edinburgh based fund management group has around £235 billion under management and advice as at 31 July 2023.

Past performance is not a guide to future performance. SAINTS is a listed UK company. As a result, the value of its shares and any income from those shares is not guaranteed and could go down as well as up. You may not get back the amount you invested. As SAINTS invests in overseas securities, changes in the rates of exchange may also cause the value of your investment (and any income it may pay) to go down or up. You can find up to date performance information about SAINTS on the SAINTS page of the Managers' website saints-it.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

For further information please contact:

James Budden, Baillie Gifford & Co

Tel: 0131 275 2000

 

Jonathan Atkins, Four Communications

Tel: 0203 920 0555 or 07872 495396

 

 

 

Third Party Data Provider Disclaimer

 

No third party data provider ('Provider') makes any warranty, express or implied, as to the accuracy, completeness or timeliness of the data contained herewith nor as to the results to be obtained by recipients of the data. No Provider shall in any way be liable to any recipient of the data for any inaccuracies, errors or omissions in the index data included in this document, regardless of cause, or for any damages (whether direct or indirect) resulting therefrom.

No Provider has any obligation to update, modify or amend the data or to otherwise notify a recipient thereof in the event that any matter stated herein changes or subsequently becomes inaccurate.

Without limiting the foregoing, no Provider shall have any liability whatsoever to you, whether in contract (including under an indemnity), in tort (including negligence), under a warranty, under statute or otherwise, in respect of any loss or damage suffered by you as a result of or in connection with any opinions, recommendations, forecasts, judgements, or any other conclusions, or any course of action determined, by you or any third party, whether or not based on the content, information or materials contained herein.

 

Sustainable Finance Disclosure Regulation ('SFDR')

 Sustainable Finance Disclosure Regulation ('SFDR')

The EU Sustainable Finance Disclosure Regulation ('SFDR') does not have a direct impact in the UK due to Brexit, however, it applies to third-country products marketed in the EU. As The Scottish American Investment Company P.L.C. is marketed in the EU by the AIFM, BG & Co Limited, via the National Private Placement Regime (NPPR) the following disclosures have been provided to comply with the high-level requirements of SFDR.

The AIFM has adopted Baillie Gifford & Co's Governance and Sustainable Principles and Guidelines as its policy on integration of sustainability risks in investment decisions.

Baillie Gifford & Co's approach to investment is based on identifying and holding high quality growth businesses that enjoy sustainable competitive advantages in their marketplace. To do this it looks beyond current financial performance, undertaking proprietary research to build an in-depth knowledge of an individual company and a view on its long-term prospects. This includes the consideration of sustainability factors (environmental, social and/or governance matters) which it believes will positively or negatively influence the financial returns of an investment.

More detail on the Managers' approach to sustainability can be found in the Governance and Sustainability Principles and Guidelines document, available publicly on the Baillie Gifford website (bailliegifford.com).

 

Taxonomy Regulation

The Taxonomy Regulation establishes an EU-wide framework of criteria for environmentally sustainable economic activities in respect of six environmental objectives. It builds on the disclosure requirements under SFDR by introducing additional disclosure obligations in respect of Alternative Investment Funds that invest in an economic activity that contributes to an environmental objective. The Company does not commit to make sustainable investments as defined under SFDR. As such, the underlying investments do not take into account the EU criteria for environmentally sustainable economic activities.

- ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR NKDBKABKDFON
Date   Source Headline
1st May 20243:20 pmRNSNet Asset Value(s)
30th Apr 202412:02 pmRNSNet Asset Value(s)
29th Apr 202411:58 amRNSNet Asset Value(s)
26th Apr 202411:47 amRNSNet Asset Value(s)
25th Apr 202411:48 amRNSNet Asset Value(s)
24th Apr 20241:08 pmRNSNet Asset Value(s)
23rd Apr 202411:56 amRNSNet Asset Value(s)
22nd Apr 202412:14 pmRNSNet Asset Value(s)
19th Apr 202412:41 pmRNSNet Asset Value(s)
18th Apr 202411:24 amRNSNet Asset Value(s)
17th Apr 202412:21 pmRNSNet Asset Value(s)
16th Apr 20244:12 pmRNSNet Asset Value(s)
15th Apr 202411:28 amRNSNet Asset Value(s)
12th Apr 202412:05 pmRNSNet Asset Value(s)
11th Apr 202411:20 amRNSNet Asset Value(s)
10th Apr 202412:47 pmRNSNet Asset Value(s)
9th Apr 202411:29 amRNSNet Asset Value(s)
8th Apr 202411:35 amRNSNet Asset Value(s)
5th Apr 20243:54 pmRNSDirector/PDMR Shareholding
5th Apr 202411:20 amRNSNet Asset Value(s)
4th Apr 20242:44 pmRNSResult of AGM
4th Apr 202412:22 pmRNSNet Asset Value(s)
3rd Apr 202411:23 amRNSNet Asset Value(s)
2nd Apr 20244:35 pmRNSNet Asset Value(s)
2nd Apr 20244:21 pmRNSNet Asset Value(s)
2nd Apr 20241:45 pmRNSNet Asset Value(s)
28th Mar 202412:31 pmRNSNet Asset Value(s)
27th Mar 202412:05 pmRNSNet Asset Value(s)
26th Mar 202412:07 pmRNSNet Asset Value(s)
25th Mar 202412:32 pmRNSNet Asset Value(s)
22nd Mar 20242:04 pmRNSNet Asset Value(s)
21st Mar 202412:22 pmRNSNet Asset Value(s)
20th Mar 202412:04 pmRNSNet Asset Value(s)
19th Mar 202411:57 amRNSNet Asset Value(s)
18th Mar 20243:33 pmRNSDirector/PDMR Shareholding
18th Mar 202411:50 amRNSNet Asset Value(s)
15th Mar 202411:22 amRNSNet Asset Value(s)
14th Mar 202411:03 amRNSNet Asset Value(s)
13th Mar 202411:49 amRNSNet Asset Value(s)
12th Mar 202411:27 amRNSNet Asset Value(s)
11th Mar 202411:10 amRNSNet Asset Value(s)
8th Mar 202412:25 pmRNSNet Asset Value(s)
7th Mar 202411:34 amRNSNet Asset Value(s)
6th Mar 20241:33 pmRNSNet Asset Value(s)
5th Mar 202412:47 pmRNSNet Asset Value(s)
4th Mar 202412:22 pmRNSNet Asset Value(s)
1st Mar 20242:05 pmRNSNet Asset Value(s)
29th Feb 20241:28 pmRNSNet Asset Value(s)
28th Feb 202411:25 amRNSNet Asset Value(s)
27th Feb 202412:26 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.